SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-14-004710
Filing Date
2014-08-11
Accepted
2014-08-11 16:14:09
Documents
7
Period of Report
2014-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 13327
2 EXHIBIT 16.1 exhibit16-1.htm EX-16.1 1653
3 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 21288
4 GRAPHIC exhibi1.jpg GRAPHIC 8938
5 GRAPHIC exhibi2.jpg GRAPHIC 3317
6 GRAPHIC exhibi3.jpg GRAPHIC 8336
7 GRAPHIC exhibi4.jpg GRAPHIC 9293
  Complete submission text file 0001062993-14-004710.txt   79141
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 141030715
SIC: 2834 Pharmaceutical Preparations